Appeal for Evaluation Data in the Public Interest for Emerging SARS-CoV-2 Diagnostic Tests
FIND is a global non-profit organization driving innovation in the development and delivery of diagnostics to combat major diseases affecting the world’s poorest populations. FIND is working closely with partners including the World Health Organization (WHO) in support of the global effort to combat the COVID-19 pandemic.
In this respect, FIND is curating the overall diagnostic pipeline and tracking reported global diagnostic use, as well as conducting independent evaluations of SARS-CoV-2 molecular tests and immunoassays.
To support public health organizations and healthcare providers around the world it is critical to have independent analytical and diagnostic performance data of the emerging tests publicly available. FIND is working to accelerate access to all global data that can help governments, healthcare institutions and global health organizations to make procurement decisions for emerging commercial SARS-CoV-2 diagnostic tests.
FIND is therefore asking partners and laboratories around the world with any performance data on commercially available in vitro diagnostic tests that detect nucleic acid, viral antigen or antibodies, to contribute to a centralized collection of data as a global public good. These data will help to inform procurement and implementation decisions for countries and health programmes, specifically those with limited capacity to conduct their own independent evaluations.
The data compilation will be made openly available on the dedicated COVID-19 section of the FIND website to enable fast data sharing throughout the diagnostic community.
This work will substantially contribute to the global effort to curb the spread and impact of COVID-19 by equipping laboratories around the world with the ability to make evidence-based decisions around diagnostic procurement. This work will inform public health institutionsincluding WHO, the Africa Centres for Disease Control and Prevention (Africa CDC), the European Centre for Disease Prevention and Control (ECDC), the African Society for Laboratory Medicine (ASLM), the Indian Council of Medical Research (ICMR), and other global stakeholders making critical supply decisions.
For more information click "LINK TO ORIGINAL" below.
This opportunity has expired. It was originally published here: